Cervical carcinoma-in-situ in woman exposed to diethylstilboestrol in utero Exposure to diethylstilboestrol (DES) in utero was shown eight years ago to be associated with vaginal adenocarcinomal; since then over 300 cases have been reported. The major risk from such DES exposure, however, may not be the development of a clear-cell adenocarcinoma but of vaginal and cervical squamous neoplasia.2 The prevalence of dysplasia in such cases is reportedly 210%,3 whereas there is an estimated fivefold increase in the incidence of carcinoma-in-situ.4 Thus there is the possibility of a vast increase in squamous malignancy as a result. The following case is apparently the first to be recorded in Great Britain of carcinoma-in-situ in a DES-exposed patient.
Case report
The patient, an unmarried woman, had been exposed to increasing doses of DES from six to 36 weeks of gestation because of a maternal history of recurrent abortion. The total dose was unknown. When she was aged 23 colposcopy showed extensive adenosis of the cervix extending on to the vaginal vault. Four years later she presented for further investigation at the Chelsea Hospital. She was nulliparous and taking oral contraceptives.
Colposcopy showed a cockscomb on the anterior lip of the cervix with pronounced punctation and aceto-white epithelium (cervical intraepithelial neoplasia grade III) in a wide transformation zone. Metaplastic changes extended on to both fornices in areas of adenosis: cytology showed dyskaryotic and malignant squames, class IV. A cone biopsy specimen was taken from the cervix, pathological examination of which showed a small os and rough nodular surface epithelium. Microscopy disclosed a squamocolumnar junction and distal immature squamous epithelium overlying endocervical glands corresponding to the area of colposcopic adenosis. Ultimately invasive carcinoma may develop in some-perhaps many -of these patients, and the greatest care in follow-up will be required. Although satisfactory healing of the areas of adenosis may occur by squamous metaplasia within a year of onset, colposcopic changes may persist for longer.5 Despite this degree of reassurance clearly great vigilance will be needed for some years before the risks can properly be evaluated. 
